Skip to content
sellWeak

OrbiMed Israel BioFund GP Limited Partnership sold $9,280 of HLSQ

owner at BiomX Inc.. 24,344 shares at an average of $0.38, traded May 15, 2024, filed May 20, 2024.

Warning score
12
Value
$9,280
24,344 shares
Holdings after
13,773,653
-0% from before
From 52-week low
+65%
low $39.90, close $65.74
From 52-week high
-50%
high $130.72, as of May 15, 2024

Score components

  • Role
    10% owner
    +12
  • Trade size
    $9k at market
    0
  • Share of holdings sold
    Sold 0.2% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -1.8%, 3m -54.4%, 6m -83.1%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

HLSQOct 13, 2026 · close 0.26
Since filing May 20, 2024: -99.6%SPY +51.1% · excess -150.7%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000947871-24-000498, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 15, 2024XIn-the-money exercise
Common Stockindirect: See footnotes
+9,280,408$0.24$2.3M13,797,997May 20, 2024
May 15, 2024SOpen-market sale
Common Stockindirect: See footnotes
-24,344$0.38$9,28013,773,653May 20, 2024
May 15, 2024XIn-the-money exercise
Warrants (Right to Buy)derivativeindirect: See footnotes
-9,280,408$0.00$00May 20, 2024

Related signals

Other insiders at BiomX Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
60Notable
HLSQsell
BiomX Inc.
Reuven Yeganeh
director, owner
$4.9M
980,000 shares
-218%
60Notable
HLSQsell
BiomX Inc.
Reuven Yeganeh
director, owner
$3.4M
670,000 shares
-223%
35Weak
HLSQsell
BiomX Inc.
Assaf Oron
Chief Business Officer
$4,072
10,914 shares
-100%
20Weak
HLSQsell
BiomX Inc.
Chidozie Ugwumba
other
$184k
288,619 shares
-8%
18Weak
HLSQsell
BiomX Inc.
Chidozie Ugwumba
other
$107k
277,247 shares
-8%
13Weak
HLSQsell
BiomX Inc.
Chidozie Ugwumba
other
$27k
74,955 shares
-2%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

OrbiMed Israel BioFund GP Limited Partnership sold $9,280 of HLSQ | InsiderTell